-
UCB Investment to Push Alpha-Synuclein Targeting Therapy into Clinical Testing
January 16, 2015
… with Belgian drugmaker UCB in a $480 million deal to study early-stage treatments for Parkinson’s disease. An MJFF … through the pipeline. N NPT200-11 is expected to move into its first clinical trial later this year. Another … Neurophage also expects to move its compound, NPT088, into clinical trials by the end of 2015. Kimberly Sawicki …
-
Shaking with Laughter: Finding Humor in a Parkinson's Disease Diagnosis
March 19, 2012
… can’t buy. As Team Fox members, the Jaffes have raised nearly $175,000 for Parkinson’s disease research through their Foundation, Shaking with Laughter . … of the disease. For those with their own Parkinson’s diagnosis or those whose loved ones are living with the …
-
17 Years after Parkinson's Diagnosis, Reflecting on the Positive
October 19, 2015
… and courage to keep fighting. All these years later, the early Pipeliners remain among my closest friends. In the …
-
-
-
Podcast: Looking Deep into Cells for the Answers to Parkinson's
May 22, 2019
… external partners talked about: Technology that is letting researchers read a person's DNA, RNA and proteins How …